Showing results (1601-1610 of 4,073) with videos related to
Sort By:
Pageof 408
Metabolic Syndrome and Related Disorders|April 9, 2009
Native platelet aggregation and response to aspirin in persons with the metabolic syndrome and its componentsDhananjay Vaidya, Lisa R Yanek, Nauder Faraday, et al.Rejuvenation Research|July 3, 2008
CD7(-) T cells are late memory cells generated from CD7(+) T cellsGunter Rappl, David Schrama, Andreas Hombach, et al.Thrombosis and Haemostasis|December 11, 2012
Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulationJeffrey S Berger, Richard C Becker, Cynthia Kuhn, et al.Journal of General Internal Medicine|February 25, 2011
Low use of opioid risk reduction strategies in primary care even for high risk patients with chronic painJoanna L Starrels, William C Becker, Mark G Weiner, et al.Nature Reviews. Disease Primers|October 27, 2017
Merkel cell carcinomaJürgen C Becker, Andreas Stang, James A DeCaprio, et al.Pain Medicine (Malden, Mass.)|October 19, 2017
Group Visits for Overdose Education and Naloxone Distribution in Primary Care: A Pilot Quality Improvement InitiativeJuliette F Spelman, Stephanie Peglow, Amy R Schwartz, et al.Journal of Personality and Social Psychology|April 20, 2011
Explaining radical group behavior: Developing emotion and efficacy routes to normative and nonnormative collective actionNicole Tausch, Julia C Becker, Russell Spears, et al.Deutsche Medizinische Wochenschrift (1946)|October 22, 2015
[Why medicine? Analyzing students' motives for studying medicine]J C Becker, D Burghaus, K Kappes, et al.Journal of the American College of Cardiology|July 10, 1999
P-selectin inhibition prevents early neutrophil activation but provides only modest protection against myocardial injury in dogs with ischemia and forty-eight hours reperfusionM Arai, Y Masui, P Goldschmidt-Clermont, et al.The Journal of Urology|December 22, 1999
Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serumC Becker, T Piironen, K Pettersson, et al.Pageof 408